Form D · Other Technology
Cleo Labs, Inc.
San Francisco, CA · CIK 0001723292
Offering snapshot reported Mar 31, 2021 · SEC filing
- Reported sold
- $40M Offering amount: $40M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 8, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 31, 2021 | Initial | $39,999,968 | No comparison | 10 | SEC filing |
| Dec 3, 2020 | Amendment | $31,221,843 | $3,839,988vs Apr 5, 2019 | 17 | SEC filing |
| Apr 5, 2019 | Initial | $27,381,855 | No comparison | 13 | SEC filing |
| Apr 5, 2019 | Initial | $2,437,618 | No comparison | 8 | SEC filing |
| Apr 5, 2019 | Initial | $11,009,989 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-394108
Series C Preferred Stock and the Common Stock issuable upon conversion thereof.
Source: Form D, filed Mar 31, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Karin Ajmani | Director |
| Michael Dixon | Director |
| Sarah Guo | Director |
| Amy Kux | Executive |
| Vanessa Larco | Director |
| Sarahjane Sacchetti | Director, Executive |
| Shannon Spanhake | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
85 2nd Street, Suite 710
San Francisco, CA, 94105
San Francisco, CA, 94105